Professional Documents
Culture Documents
Pneumonia
Acute inflammatory process of the alveolar spaces lung consolidation exudate [alveoli]
Classification
CAP: most common; occurs in the community or 48 H before hospitalization S. pneumoniae, H. influenza, M. pneumoniae Nosocomial: onset of S/S is 48-72 H posthospitalization P. aeruginosa, S. pneumoniae, K. pneumoniae
Pneumonia
Types
Bacterial pneumonia Lobar [Strep] constant dry, hacking cough, pleuritic pain, watery to rust-colored sputum Bronchopneumonia [Strep/Staph] due to aspiration, productive cough w/ yellow or green sputum Alveolar pneumonia [viral] scanty sputum Atypical pneumonia [rickettsial] walking, nonproductive cough
nionoveno@hc respi disorders 3
Pneumonia
Cough Chills Dyspnea Elevated temperature Crackles Rhonchi Pleural friction rub Sputum production Rusty, green, or bloody: pneumococcal Yellow-green: BPN
Clinical Manifestations
nionoveno@yc
respi disorders
Pneumonia
Opportunistic infection Often related to HIV & other immunocompromised conditions Clinical Manifestations Increasing SOB Nonproductive cough Low-grade fever
Pneumonia
Management Increase OFI 3-4 L/day. Administer O2. Assess respiratory status. Monitor VS, I/O, lab studies, & pulse ox Monitor & record color, consistency, & amount of sputum Home care Recognize s/sx of infection. Avoid exposure to people with infections. Increase OFI at 3 L/day.
nionoveno@yc respi disorders 6
Bronchitis
Emphysema
Causes Congenital weakness Respiratory irritants: smoke, polluted air, chemical irritants Respiratory tract infections Genetic predisposition
nionoveno@yc respi disorders 7
Inflammation
Bradykinin, Histamine, PGs Capillary permeability Fluid/Cellular Exudation Mucosal edema
Hypersecretion of mucus
Persistent Cough
respi disorders 8
Emphysema
Destruction of elastin alters alveolar walls & narrows airways Enlargement of air spaces distal to terminal bronchioles leads to coalesced alveoli & air trapping
9
respi disorders
Emphysema
No cyanosis (Pink) Thin appearance Exertional dyspnea Ineffective cough Barrel chest Pursed-lip breathing Prolonged expiration Use of accessory muscles
Chronic Bronchitis
Cyanosis (Blue) Edematous Exertional dyspnea Recurrent cough w/ Sputum production Digital clubbing Respiratory rate Use of accessory muscles
R-sided Heart Failure R-sided Heart Failure Pulmonary HPN Cor pulmonale Spontaneous pneumothorax respi disorders nionoveno@yc
10
Bronchiectasis
Destruction of bronchial mucosa with fibrous scar tissue formation Loss of resilience & airway dilation causes pooling of secretions Obstruction of airflow
nionoveno@yc respi disorders 12
Hypoventilation
Air trapping
Clinical Manifestations
Management
Corticosteroids Anticholinergics [Atropine] Mast cell inhibitors [Cromolyn] Oxygen via nasal cannula Fluids to 3L/day Breathing exercises Metered dose inhaler
14
respi disorders
nionoveno@yc
respi disorders
16
Management
Diagnostics
respi disorders
17
Chest Physiotherapy
Postural drainage Percussion Vibration
Nursing Care
Perform before or 3-4 hrs after meal Bronchodilators 15-20 mins before Remove all tight clothing Percuss on area approx 3mins during I & E Vibrate on area during E Assist pt in coughing & positioning Provide good oral hygiene
nionoveno@yc respi disorders 18
nionoveno@yc
respi disorders
19
Pulmonary Tuberculosis
Airborne, infectious, communicable Acute or chronic Mycobacterium tuberculosis Clinical Manifestations Fatigue, malaise Anorexia, weight loss Night sweats Late afternoon low-grade fever Productive chronic cough Hemoptysis (advanced)
nionoveno@yc
respi disorders
20
Pulmonary Tuberculosis
Mantoux test Read after 48-72 H [>10 mm induration] Chest x-ray Calcified lesions Sputum exam Acid-fast bacillus
Diagnostics
TB medications [6-12 mos] INH, RIF, (6 mos); PZA, ethambutol, streptomycin (2 mos) Pt non-infectious 2-3wks of Tx 9 mos continuous therapy
Management
RIF: discoloration ; hepatotoxic INH: peripheral neuropathy (B6), liver function test (AST, ALT) PZA: thrombocytopenia, hyperurecemia OFI ETHAMBUTOL: optic neuritis STREPTOMYCIN: hepatotoxic, nephrotoxic, ototoxic, given IM
nionoveno@yc respi disorders 21
nionoveno@yc
respi disorders
22
Management
High-Fowlers Pain relief O2 therapy Chest tube insertion Thoracentesis Chest x-ray ABGs Monitor for shock
23
Pulmonary Embolism
Undissolved substance in pulmonary vasculature obstructs blood flow Types: Fat, Air, Thrombus Causes Flat or long bone fractures Thrombophlebitis Venous stasis
nionoveno@yc respi disorders 24
Pulmonary Embolism
Clinical Manifestations
Dyspnea, tachypnea, crackles
Diagnostics
ABGs Respiratory alkalosis, hypoxemia Lung Scan Pulmonary circulation & blood flow obstruction Angiography Location of embolus Filling defect of pulmonary artery
nionoveno@yc respi disorders 25
Pulmonary Embolism
Management
Intubation & mechanical ventilation Anticoagulants Thrombolytics Assess for (+) Homans sign Monitor PT & PTT WOF S/S of excessive anticoagulation
nionoveno@yc
respi disorders
26
Bronchogenic Carcinoma
Primary pulmonary tumors arising from bronchial epithelium; metastasis primarily by direct extension, via the circulatory or the lymphatic systems Incidence Men > 40 years; 1 out of 10 heavy smokers Right lung > Left lung Etiology Inhaled carcinogens [cigarette smoke, asbestos, nickel, iron oxides] Pre-existing pulmonary DO [COPD, TB]
nionoveno@yc respi disorders 27
Bronchogenic Carcinoma
Clinical Manifestations
Persistent cough [productive, blood-tinged] Chest pain, dyspnea Unilateral wheezing Friction rub Fatigue, anorexia Nausea & vomiting Pallor
nionoveno@yc respi disorders
Diagnostics
CXR Presence of tumor; metastasis Sputum for cytology Malignant cells Thoracentesis Pleural fluid with malignant cells
28
Bronchogenic Carcinoma
Management
Depends on cell type, stage of disease, and condition of the patient Radiation therapy Chemotherapy Surgery Provide support & guidance to client Relief/control of pain and nausea Meds as ordered, monitor effects
nionoveno@yc respi disorders 29
Lung Cancer
Maybe metastatic or primary Leading cause of mortality Smoking-related Poor prognosis Dies in 5 years Adenocarcinoma Most prevalent type Small cell carcinoma Poorest prognosis
nionoveno@yc respi disorders 30
Laryngeal Carcinoma
Risk Factors
Cigarette smoking Chronic laryngitis Vocal abuse Alcohol abuse Familial tendency
Types
Glottic Hoarseness for >2 weeks Dyspnea Supraglottic Localized throat pain Burning when drinking hot liquids or orange juice Lump in the neck Dysphagia, odynophagia
respi disorders 31
nionoveno@yc
Laryngeal Carcinoma
Management
Subtotal laryngectomy: retains voice Total: absolute loss of voice Tracheostomy: temporary or permanent Maintain patent airway HOB elevated 45 Assist patient in communicating; provide writing materials, etc. Practice swallowing Cover tracheostomy with porous material Avoid powder, spray, aerosol near trachea
nionoveno@yc respi disorders 32
THANK YOU!
Respiratory Disorders
Nio C. Noveno, RN ,MAN